These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8103764)

  • 1. The analysis of plasma kinetics and beta-receptor binding and -blocking activity of timolol following its small intravenous dose.
    Kaila T; Karhuvaara S; Huupponen R; Iisalo E
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):351-7. PubMed ID: 8103764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ophthalmic beta-blockers: determination of plasma and aqueous humor levels by a radioreceptor assay following multiple doses.
    Phan TM; Nguyen KP; Giacomini JC; Lee DA
    J Ocul Pharmacol; 1991; 7(3):243-52. PubMed ID: 1686051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-653,328: an ocular hypotensive agent with modest beta receptor blocking activity.
    Sugrue MF; Gautheron P; Grove J; Mallorga P; Viader MP; Baldwin JJ; Ponticello GS; Varga SL
    Invest Ophthalmol Vis Sci; 1988 May; 29(5):776-84. PubMed ID: 2896641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops.
    Korte JM; Kaila T; Saari KM
    Graefes Arch Clin Exp Ophthalmol; 2002 Jun; 240(6):430-5. PubMed ID: 12107508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenergic receptors in the elderly are not less sensitive to timolol.
    Klein C; Gerber JG; Gal J; Nies AS
    Clin Pharmacol Ther; 1986 Aug; 40(2):161-4. PubMed ID: 3015473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathoracic ganglionic beta-adrenergic receptors involved in efferent sympathetic regulation of the canine heart.
    Armour JA; Butler C
    Can J Cardiol; 1989; 5(5):275-83. PubMed ID: 2569357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICI 118,551: an effective ocular hypotensive agent with selectivity for the ciliary process beta 2-adrenoceptor and with minimal cardiac side effects.
    Nathanson JA
    Br J Pharmacol; 1984 Nov; 83(3):821-9. PubMed ID: 6150744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereospecific binding of timolol, a beta-adrenergic blocking agent.
    Tocco DJ; Hooke KF; Deluna FA; Duncan AE
    Drug Metab Dispos; 1976; 4(4):323-9. PubMed ID: 8286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological evaluation of ocular beta-adrenoceptors in rabbit by tissue segment binding method.
    Horinouchi T; Morishima S; Tanaka Y; Koike K; Miwa S; Muramatsu I
    Life Sci; 2009 Jan; 84(5-6):181-7. PubMed ID: 19087880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic analysis of systemic effect of topically applied timolol maleate ophthalmic gelling vehicle (Rysmon TG).
    Ohno Y; Iga T; Yamada Y; Nagahara M; Araie M; Takayanagi R
    Curr Eye Res; 2005 Apr; 30(4):319-28. PubMed ID: 16020262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma kinetics and antagonist activity of topical ocular timolol in elderly patients.
    Vuori ML; Kaila T
    Graefes Arch Clin Exp Ophthalmol; 1995 Mar; 233(3):131-4. PubMed ID: 7758979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blocking effects of timolol at low plasma concentrations.
    Kaila T; Huupponen R; Karhuvaara S; Havula P; Scheinin M; Iisalo E; Salminen L
    Clin Pharmacol Ther; 1991 Jan; 49(1):53-8. PubMed ID: 1846331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Asthma and beta-blocker eye drops (timolol, metipranolol, carteolol). Inhibition of chronotropic effects of isoprenaline].
    Le Jeunne C; Munera Y; Teillet L; Hugues FC
    Allerg Immunol (Paris); 1988 Sep; 20(7):267-9. PubMed ID: 2902862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor binding characteristics and pharmacokinetic properties as a tool for the prediction of clinical effects of beta-blockers.
    Wellstein A; Palm D; Belz GG; Pitschner HF
    Arzneimittelforschung; 1985; 35(1):2-6. PubMed ID: 2859024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sensitive radioligand binding assay for timolol in plasma.
    Kaila T
    J Pharm Sci; 1991 Mar; 80(3):296-9. PubMed ID: 1675681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between pharmacological response, kinetics of plasma concentration and in vitro receptor affinities exemplified with beta-adrenoceptor blocking drugs.
    Wellstein A; Palm D
    Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):641-4. PubMed ID: 6151037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and bioelectrical effects of cyclic adenosine monophosphate production in the ciliary epithelial bilayer.
    Horio B; Sears M; Mead A; Matsui H; Bausher L
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):607-12. PubMed ID: 8595960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro receptor occupancy allows to establish equieffective doses of beta-blockers with different pharmacodynamic profiles in man. Investigations with propranolol and bufuralol.
    Wellstein A; Palm D; Matthews JH; Belz GG
    Methods Find Exp Clin Pharmacol; 1985 Dec; 7(12):645-51. PubMed ID: 3007897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta 1- and beta 2-antagonist activity of topically applied betaxolol and timolol in the systemic circulation.
    Vuori ML; Ali-Melkkilä T; Kaila T; Iisalo E; Saari KM
    Acta Ophthalmol (Copenh); 1993 Oct; 71(5):682-5. PubMed ID: 7906474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.